One study performed a gain-of-function screen for tumor resistance against T cell cytotoxicity and identified CD274, MCL1, JUNB, and B3GNT2 which enable melanoma cells to evade CTL killing (Joung et al., 2022). This evidence concerns the gene CD274 and neoplasm.